GlassScriptPhysician profile
Christopher F Barnett
NPI 1538127717
$36,282.43
in general payments reported to CMS, 2019-2025
21 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.04 · 2020: $263 · 2021: $128 · 2022: $756 · 2023: $3,797 · 2024: $14K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,425 · Travel and Lodging: $5,260 · Honoraria: $5,100 · Food and Beverage: $4,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,667.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,425.00 |
| Travel and Lodging | $5,260.29 |
| Honoraria | $5,100.00 |
| Food and Beverage | $4,654.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23,693.22 | 2023-2025 | Freestyle Libre Pro, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,500.00 | 2023-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $1,956.64 | 2023-2025 | |
| Pfizer INC. | $1,793.86 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $1,216.01 | 2021-2025 | Opsumit, Uptravi |
| Abiomed | $1,084.56 | 2022-2025 | Impella |
| Merck Sharp & Dohme LLC | $761.98 | 2022-2025 | Winrevair |
| United Therapeutics Corporation | $437.60 | 2022-2025 | |
| Boston Scientific Corporation | $181.93 | 2020 | |
| Impulse Dynamics (USA) INC. | $150.00 | 2024 | Optimizer |
| Getinge USA Sales, LLC | $111.66 | 2023 | Cardiohelp |
| Amgen INC. | $109.78 | 2020-2021 | |
| Johnson & Johnson Health Care Systems INC. | $108.13 | 2024 | Uptravi |
| Sandoz INC. | $49.04 | 2025 | Treprostinil |
| Ethicon US, LLC | $39.47 | 2024 | Monocryl, Stratafix |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $28.63 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cook Medical LLC | $27.04 | 2019 | |
| Angiodynamics, INC. | $17.39 | 2025 | Alphavac |
| Medtronic, INC. | $15.49 | 2024 | Invos |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.